BioSpace News Archive

Business

Innovent Licenses Use Of Harbour Biomed’s Biologic Drug Discovery Platform

Suzhou’s Innovent Biologics will use a proprietary H2L2 transgenic mouse platform owned by Harbour Biomed of Shanghai to discover new mAbs.

October 16, 2017

·

1 min read

Biotech Bay

Genentech To Present New OCREVUS (Ocrelizumab) Efficacy & Safety Data In Relapsing And Primary Progressive Forms Of Multiple Sclerosis At ECTRIMS

Genentech announced today that new data on OCREVUS (ocrelizumab) in people with relapsing and primary progressive forms of multiple sclerosis (MS) will be presented during the 7th Joint European Committee for Treatment and Research in Multiple Sclerosis.

October 16, 2017

·

15 min read

Drug Development

Chi-Med Reports Preliminary Phase II Data On Fruquintinib Combination In First-Line Lung Cancer

Hutchison China MediTech Limited today reported preliminary clinical activity, safety, and tolerability data of fruquintinib.

October 16, 2017

·

6 min read

Genetown

Takeda Presents Updated Results From Pivotal Phase II ALTA Trial Of ALUNBRIGTM (Brigatinib) In ALK-Positive Non-Small Cell Lung Cancer

Takeda Pharmaceutical Company Limited today announced that data from the pivotal Phase 2 ALTA will be presented in an oral session at the International Association for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer (WCLC) on Monday, October 16, 4:30 p.m.- 4:40 p.m. JST.

October 16, 2017

·

16 min read

Business

QIAGEN N.V. To Report Third Quarter And First Nine Months Of 2017 Results

QIAGEN N.V. plans as previously announced to release its report on results for the third quarter and first nine months of 2017 on Monday, November 6 at approximately 22:00 Central European Time (CET) / 16:00 Eastern Time (EDT).

October 16, 2017

·

2 min read

Drug Development

Nanology Announces First Patient Enrolled In A Phase II Clinical Trial Of Nanopac For Treatment Of Prostate Cancer

NanOlogy LLC today announced the first patient has been enrolled in a clinical trial of NanoPac (nanoparticle paclitaxel) sterile suspension administered into the prostate for treatment of prostate cancer.

October 16, 2017

·

5 min read

Drug Development

Eli Lilly Release: Rapidly Progressing Advanced Non-Small Cell Lung Cancer Patients Shown To Benefit In New CYRAMZA (Ramucirumab) Phase III Subgroup Analysis

New subgroup analysis from Eli Lilly’s Phase 3 REVEL trial of CYRAMZA (ramucirumab) in advanced non-small cell lung cancer (NSCLC) was presented today at the 18th World Conference on Lung Cancer (WCLC).

October 16, 2017

·

29 min read

Lone Star Bio

Trievr To Provide Major Pharmas With Request Management Platform To Meet New FDA Quality Metrics Requirements

Trievr today announced that three of the top 10 major pharmaceutical companies have signed with Trievr to help facilitate and simplify the new FDA Quality Metrics (QM) Requirements.

October 16, 2017

·

2 min read

Genetown

Foundation Medicine to Present Validation for FoundationOne CDx

Foundation Medicine will present validation data for FoundationOne CDx at the International Association for the Study of Lung Cancer 18th World Conference on Lung Cancer.

October 16, 2017

·

6 min read

Biotech Beach

Ignyta Issued Four Inducement Awards

Ignyta, Inc., a biotechnology company focused on precision medicine in oncology, announced today that it has issued four inducement awards to new non-executive employees.

October 16, 2017

·

1 min read